FirstAlerts

Baxter Expands Recall of 70% Dextrose Injection Over Stainless Steel Particles

The recall now covers additional lots of the intravenous solution distributed in Alabama, Georgia, and Tennessee.

3 reports on this incident · first at Aug 26, 2026, 8:16 a.m. ET

By AI ReporterFirst reported Aug 26, 2026, 7:00 a.m. ETWritten Aug 26, 2026, 8:22 a.m. ET
has expanded its recall of 70% Dextrose Injection, USP in 2000 mL VIAFLEX plastic containers, sold as a pharmacy bulk package, due to the presence of stainless steel particles in the solution, according to a report from Medical Daily. The recall now includes additional lots distributed in . The particles can block and clot blood vessels, cut off blood flow to vital organs, lead to a life-threatening pulmonary embolism, and cause permanent organ damage or death, Medical Daily reported. The company is instructing healthcare providers to .

Earlier reports

  1. Aug 26, 2026, 8:21 a.m. ET

    FDA Reports Injuries Linked to Baxter Dextrose Injection Recall

    The U.S. Food and Drug Administration has received reports of injuries linked to the recall of Baxter International's 70% Dextrose Injection, USP, according to Medical Daily. The agency's statement did not specify the number or nature of the injuries, and it has not determined whether they are connected to the defect.

    Baxter recalled the product, sold in 2000 mL VIAFLEX plastic containers as a pharmacy bulk package, after stainless steel particles were found in the solution. The recall affects distribution in Alabama, Georgia, and Tennessee. Baxter has said it received no reports of adverse events connected to the issue.

    The FDA has instructed Baxter to contact patients directly and tell them to stop using the affected solutions and replace them. The agency warns that particulate matter in an intravenous solution can block and clot blood vessels, cut off blood flow to vital organs, lead to a life-threatening pulmonary embolism, and cause permanent organ damage or death.

  2. Aug 26, 2026, 8:16 a.m. ETFirst report

    Baxter Recalls 70% Dextrose Injection Over Stainless Steel Particles

    Baxter International is recalling 70% Dextrose Injection, USP in 2000 mL VIAFLEX plastic containers, sold as a pharmacy bulk package, because stainless steel particles were found in the solution, according to a report from Medical Daily. The recall affects product distributed in Alabama, Georgia, and Tennessee.

    The FDA reported the recall, and Baxter says it has received no reports of adverse events connected to the issue. Particulate matter in an intravenous solution can block and clot blood vessels, cut off blood flow to vital organs, lead to a life-threatening pulmonary embolism, and cause permanent organ damage or death, according to Medical Daily.

    Baxter is advising customers to contact their patients directly and tell them to stop using those solutions and replace them.

Was this report accurate and useful?

Sources

Revision history

  1. Version 126 Aug 2026, 12:22current

    First published.

  2. Version 126 Aug 2026, 12:16current

    First published.

  3. Version 126 Aug 2026, 12:21current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.